Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Synthesis and Evaluation of Astatinated N-[2-(Maleimido)ethyl]-3-(trimethylstannyl)benzamide Immunoconjugates

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Affinity-Guided Conjugation to Antibodies for Use in Positron Emission Tomography

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Oxime Coupling of Active Site Inhibited Factor Seven with a Nonvolatile, Water-Soluble Fluorine-18 Labeled Aldehyde

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Molecular Targeted NIR-II Probe for Image-Guided Brain Tumor Surgery

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Preclinical Study on GRPR-Targeted (68)Ga-Probes for PET Imaging of Prostate Cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Towards elucidating the radiochemistry of astatine - Behavior in chloroform

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Multifunctional Clickable Reagents for Rapid Bioorthogonal Astatination and Radio-Crosslinking

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Extraction of 211At from nitric acid solutions into various organic solvents for use as an α-source for radiation chemistry studies

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Emma Aneheim
  • Anna Gustafsson
  • Per Albertsson
  • Tom Bäck
  • Holger Jensen
  • Stig Palm
  • Sofia Svedhem
  • Sture Lindegren
View graph of relations

Effective treatment of metastasis is a great challenge in the treatment of different types of cancers. Targeted alpha therapy utilizes the short tissue range (50-100 μm) of α particles, making the method suitable for treatment of disseminated occult cancers in the form of microtumors or even single cancer cells. A promising radioactive nuclide for this type of therapy is astatine-211. Astatine-211 attached to tumor-specific antibodies as carrier molecules is a system currently under investigation for use in targeted alpha therapy. In the common radiolabeling procedure, astatine is coupled to the antibody arbitrarily on lysine residues. By instead coupling astatine to disulfide bridges in the antibody structure, the immunoreactivity of the antibody conjugates could possibly be increased. Here, the disulfide-based conjugation was performed using a new coupling reagent, maleimidoethyl 3-(trimethylstannyl)benzamide (MSB), and evaluated for chemical stability in vitro. The immunoconjugates were subsequently astatinated, resulting in both high radiochemical yield and high specific activity. The MSB-conjugate was shown to be stable with a long shelf life prior to the astatination. In a comparison of the in vivo distribution of the new immunoconjugate with other tin-based immunoconjugates in tumor-bearing mice, the MSB conjugation method was found to be a viable option for successful astatine labeling of different monoclonal antibodies.

Original languageEnglish
JournalBioconjugate Chemistry
Volume27
Issue number3
Pages (from-to)688-97
Number of pages10
ISSN1043-1802
DOIs
Publication statusPublished - 16 Mar 2016

    Research areas

  • Animals, Astatine, Benzamides, Immunoconjugates, Mice, Mice, Inbred BALB C, Journal Article, Research Support, Non-U.S. Gov't

ID: 49714253